Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
…months of therapy. Wilcoxon matched paired tests were used to assess differences between baseline and 6 months’ results. p Values were corrected using the Bonferroni test. Results: Ocrelizumab reduced the numbers of naive…
read more